The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome. - Wikidata - awgldk - TriplyDB

The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome.

The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome.

http://www.wikidata.org/entity/Q34248518

about

Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: Part II - contemporary contextual research Rifaximin for Irritable Bowel Syndrome: A Meta-Analysis of Randomized Placebo-Controlled Trials Obesity as a consequence of gut bacteria and diet interactions Acne vulgaris, probiotics and the gut-brain-skin axis: from anecdote to translational medicine Disruption of the human gut microbiota following Norovirus infection Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy The microbiota-gut-brain axis in functional gastrointestinal disorders.A role for the gut microbiota in IBS.Autoimmunity Links Vinculin to the Pathophysiology of Chronic Functional Bowel Changes Following Campylobacter jejuni Infection in a Rat Model.Comparison of the antibacterial activity of essential oils and extracts of medicinal and culinary herbs to investigate potential new treatments for irritable bowel syndrome.The impact of proton pump inhibitors on the human gastrointestinal microbiome Antibiotics for irritable bowel syndrome: rationale and current evidence.Small bowel bacterial overgrowth in patients with irritable bowel syndrome: the first study in iran Overgrowth of the indigenous gut microbiome and irritable bowel syndrome.Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets.Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome.Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects.Role of the Gut Microbiome in Obesity and Diabetes Mellitus.Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea.Rifaximin for the treatment of irritable bowel syndrome - a drug safety evaluation.Small intestinal bacterial overgrowth is associated with irritable bowel syndrome and is independent of proton pump inhibitor usage.Small Intestinal Bacterial Overgrowth in Patients with Refractory Functional Gastrointestinal Disorders.Lactulose Hydrogen Breath Test Result Is Associated with Age and Gender The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease.Low Paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortality The use of non-narcotic pain medication in pediatric gastroenterology.Irritable Bowel Syndrome and the Small Intestinal Microflora. What Do We Know?Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth.Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.How to Test and Treat Small Intestinal Bacterial Overgrowth: an Evidence-Based Approach.Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea.Post-infectious IBS, tropical sprue and small intestinal bacterial overgrowth: the missing link.Small intestinal bacterial overgrowth: duodenal aspiration vs glucose breath test.Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus.Draft Genome Sequence of Enterococcus sp. Strain HSIEG1, Isolated from the Human Small Intestine.Commentary: associations between immune activation, intestinal permeability and irritable bowel syndrome.A definitive blood test for post-infectious irritable bowel syndrome?Aciduric Strains of Lactobacillus reuteri and Lactobacillus rhamnosus, Isolated from Human Feces, Have Strong Adhesion and Aggregation Properties.Gut Microbiota-Based Therapies for Irritable Bowel Syndrome.Antibiotic treatment of constipation-predominant irritable bowel syndrome.

P2860

Q21198786-AE16CACB-6053-4907-BF36-9C3CF95B15CD Q26772962-EE522A58-4D41-4895-ACC1-C565275C4841 Q27001257-A98903E4-6127-4482-87D7-B5ABFE9C1BAE Q28295293-1F57954B-6A4E-48D2-BA8E-DE7CF9E308E1 Q30424368-BEE7B2D8-0C5F-43F8-ABAF-64FECAC05AF2 Q33469991-D2E832CB-4D4B-4CCD-BE30-20F39571DF7C Q34129427-E484654E-B5D6-4A67-8C37-BFD9EB06A599 Q34416297-BAA2D97E-CE6A-4267-B26C-B856996F905D Q34449503-40C32906-37E2-4FF1-B9D9-C5F6E9EE362C Q34454007-9C604291-CA2D-49BF-8060-C06585C6749A Q34625008-58E882FF-DA37-4788-9620-96E2CEA7DB7B Q34642080-B5AB4344-C6EB-4E65-81BD-DA149749B8DA Q34950787-4F03835C-8F20-4920-87E2-3222B6486BB8 Q35120395-E7EDF9FC-C675-4A64-AB7C-CF3132C387D3 Q35130485-C8A27E9F-3837-4D9C-8B5B-84CB0235EAF9 Q35599906-448E5F9C-C1ED-4892-8EF5-51AD7879A5A7 Q35603014-4616E9AA-F2A6-4B04-BBBD-ECEC5EF19AE1 Q35801939-0DEA6FCB-3792-4C48-8C18-908982C9F60F Q35855740-E2736C28-87D3-4707-A7EA-4CC469F575C0 Q36009729-E86410A7-848C-4C3B-AE61-BDD869928938 Q36073385-A1016A83-0649-4214-A11D-84602DF70640 Q36426034-87925397-FE58-47B4-8727-837183776884 Q36747480-6DA326C2-C1AD-4D9B-867F-2DAC30DD6D5C Q36751990-54131446-828D-4231-8258-6D6E346EF403 Q37113096-752C0471-36EE-422F-A71C-2C287B866629 Q38221358-11009429-60DE-404A-B52B-431247A282FF Q38528094-47DB5BF4-6276-42F9-A202-FF13BDC4D455 Q38645247-ECC98952-9585-4928-B574-7896FD4F6939 Q38692607-6C7894B0-64BF-4972-AC4D-420040FF5C5F Q38701265-7A976443-D6CB-4E60-A2D2-74C7694BB7AB Q38988993-9E6E97B8-1BBE-426D-B000-C1A426DC50FD Q39022623-D467DD59-16EB-4575-9940-ACC35222BBE4 Q41534928-6285937C-4788-4460-A8A5-0AB4EADC800C Q42289564-8BB5F96F-3A73-4FD0-924E-3694C2BB2E5C Q42802514-B2D4FAA0-CCD4-406A-B01D-429E744FACED Q45912540-34CE9CA6-3636-4B26-8A9E-37882F1B61CC Q46484371-E5A3FF8A-F3E0-4416-86C2-8CBDEE5F69D4 Q46971057-F126B2D8-A9A2-4980-B85C-8C0ED3ABA492 Q49985626-02A2C9E9-63DE-412B-A1D3-E44A3FFA3628 Q51726426-9579654C-0FA6-4C20-8ABE-F6511BA12551

P2860

The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome.

http://www.wikidata.org/entity/Q34248518

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

The prevalence of overgrowth b ...... with irritable bowel syndrome.

@ast

The prevalence of overgrowth b ...... with irritable bowel syndrome.

@en

The prevalence of overgrowth b ...... with irritable bowel syndrome.

@nl

type

label

The prevalence of overgrowth b ...... with irritable bowel syndrome.

@ast

The prevalence of overgrowth b ...... with irritable bowel syndrome.

@en

The prevalence of overgrowth b ...... with irritable bowel syndrome.

@nl

prefLabel

The prevalence of overgrowth b ...... with irritable bowel syndrome.

@ast

The prevalence of overgrowth b ...... with irritable bowel syndrome.

@en

The prevalence of overgrowth b ...... with irritable bowel syndrome.

@nl

P1433

Q34248518-965BC1CA-8412-4324-849C-B091EEFCBB48

P1476

Q34248518-73965BE9-E2B2-46B0-9EB7-5093C4BB4DD3

P2093

Q34248518-6D21CC70-2BD6-451B-981F-C686B8CE94FD

Q34248518-93541FA1-A716-4A18-B927-52B104188EA9

Q34248518-9492C3E8-C089-40F5-ACAE-75509AF538E5

Q34248518-B2E001AB-D356-4F9F-8B7C-0F696A87CAB3

Q34248518-CB4D4C22-4F27-479A-B46F-7627B48618E4

P2860

Q34248518-021214ED-40B4-4B39-AA88-D2E34D14C93F

Q34248518-12CD0DE8-2459-4439-9089-F597AFD2A2AA

Q34248518-131DEF02-AAD8-4B07-87CF-1D6C00A3DA24

Q34248518-19F897CB-7186-49E4-B812-F4B7E79BF359

Q34248518-25F65240-B97F-4F23-B928-9EAF0ADE0EE2

Q34248518-27ADD306-4BC5-4143-BE66-55D4A01FC336

Q34248518-2D470278-DBB2-425E-8E7D-4681FEDD2821

Q34248518-2E7733DA-E3AB-4410-A6A0-8B323E9753EA

Q34248518-466FE769-2C85-4AAE-91EE-94A60FA6E1A6

Q34248518-468DE3C8-C7DF-49F4-828A-78C8802869DE

P2888

Q34248518-2F57AF01-216D-49FB-8153-5781C27567D0

P304

Q34248518-FEA02F42-4FB6-4B10-AACD-EC0D18B2E45B

P31

Q34248518-CDF4DFC1-7304-46FD-AA5E-E9125F00E6F6

P356

Q34248518-CFF42EC9-4B77-4849-99DA-54E2B896580D

P433

Q34248518-1ECF331A-26B5-4CE7-A99A-E193CCB09261

P478

Q34248518-8AA6B40D-0E9D-42C2-A9C0-369777ED8D71

P50

Q34248518-1D597BC6-B6C5-4E54-8025-563222A44015

P577

Q34248518-8D2C3798-4E90-4839-98E6-3C59DC0E9B84

P5875

Q34248518-B1F0E9AF-723A-41A0-9EB3-75EAF776526F

P6179

Q34248518-F6FEFB62-7382-4004-8260-9BE1CE2868E1

P698

Q34248518-5B2AF99D-757C-448A-8C70-5AC3F41A1D00

P356

S10620-012-2033-7

P1433

Digestive Diseases and Sciences

P1476

The prevalence of overgrowth b ...... with irritable bowel syndrome.

@en

P2093

Charalambos Barbatzas

http://www.w3.org/2001/XMLSchema#string

Dimitrios Tzivras

http://www.w3.org/2001/XMLSchema#string

Emmannouil Pyleris

http://www.w3.org/2001/XMLSchema#string

Evangelos J Giamarellos-Bourboulis

http://www.w3.org/2001/XMLSchema#string

Vassilios Koussoulas

http://www.w3.org/2001/XMLSchema#string

P2860

Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?

Small intestinal bacterial overgrowth in patients with irritable bowel syndrome

A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence

Rifaximin therapy for patients with irritable bowel syndrome without constipation

Prevalence of cardiovascular risk factors and the metabolic syndrome in middle-aged men and women in Gothenburg, Sweden.

Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS.

Bacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors?

The pathogenesis of gastrointestinal bacterial overgrowth.

Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth.

Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome.

P2888

s10620-012-2033-7

P304

1321-1329

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10620-012-2033-7

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221763721

http://www.w3.org/2001/XMLSchema#string

P6179

1022361939

http://www.w3.org/2001/XMLSchema#string

P698

22262197

http://www.w3.org/2001/XMLSchema#string